Search research articles
Contact Us
Filters
Showing results (21-30 of 106) with videos related to
Page
of 11
Sort By:
Urology
|
March 15, 2001
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder
P Van Kerrebroeck, K Kreder, U Jonas, et al.
Cancer
|
December 18, 2001
High-risk groups of patients with Stage II colon carcinoma
S Merkel, A Wein, K Günther, et al.
Neurourology and Urodynamics
|
May 1, 2010
Neurological patients need evidence-based urological care
J J Wyndaele, H Bruschini, H Madersbacher, et al.
Cancer Treatment Reports
|
June 1, 1980
Tamoxifen in refractory metastatic carcinoma of the prostate
J H Glick, A Wein, K Padavic, et al.
MMW Fortschritte Der Medizin
|
September 20, 2001
[Prevention and therapy of diabetic foot syndrome. Preventing complications]
B Hanke, I A Harsch, H Bock, et al.
Clinical Performance and Quality Health Care
|
September 5, 1993
The use of clinical parameters in an interactive statistical package to predict pathological features associated with local failure after radical prostatectomy for prostate cancer
A D'Amico, M Altschuler, R Whittington, et al.
Cancer
|
April 1, 1982
Phase II trial of tamoxifen in metastatic carcinoma of the prostate
J H Glick, A Wein, K Padavic, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
December 29, 2000
[Hepatic Doppler perfusion index--a sensitive screening method for detecting liver metastases?]
S Krüger, D Strobel, M Wehler, et al.
Cancer Treatment Reports
|
February 1, 1980
Phase II study of tamoxifen in patients with advanced renal cell carcinoma
J H Glick, A Wein, S Torri, et al.
International Journal of Clinical Practice
|
October 1, 2013
Comorbidities and personal burden of urgency urinary incontinence: a systematic review
K S Coyne, A Wein, S Nicholson, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 106) with videos related to
Sort By:
Page
of 11
Urology
|
March 15, 2001
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder
P Van Kerrebroeck, K Kreder, U Jonas, et al.
Cancer
|
December 18, 2001
High-risk groups of patients with Stage II colon carcinoma
S Merkel, A Wein, K Günther, et al.
Neurourology and Urodynamics
|
May 1, 2010
Neurological patients need evidence-based urological care
J J Wyndaele, H Bruschini, H Madersbacher, et al.
Cancer Treatment Reports
|
June 1, 1980
Tamoxifen in refractory metastatic carcinoma of the prostate
J H Glick, A Wein, K Padavic, et al.
MMW Fortschritte Der Medizin
|
September 20, 2001
[Prevention and therapy of diabetic foot syndrome. Preventing complications]
B Hanke, I A Harsch, H Bock, et al.
Clinical Performance and Quality Health Care
|
September 5, 1993
The use of clinical parameters in an interactive statistical package to predict pathological features associated with local failure after radical prostatectomy for prostate cancer
A D'Amico, M Altschuler, R Whittington, et al.
Cancer
|
April 1, 1982
Phase II trial of tamoxifen in metastatic carcinoma of the prostate
J H Glick, A Wein, K Padavic, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
December 29, 2000
[Hepatic Doppler perfusion index--a sensitive screening method for detecting liver metastases?]
S Krüger, D Strobel, M Wehler, et al.
Cancer Treatment Reports
|
February 1, 1980
Phase II study of tamoxifen in patients with advanced renal cell carcinoma
J H Glick, A Wein, S Torri, et al.
International Journal of Clinical Practice
|
October 1, 2013
Comorbidities and personal burden of urgency urinary incontinence: a systematic review
K S Coyne, A Wein, S Nicholson, et al.
Page
of 11